Supplemental oxygen therapy use among patients with fibrosing interstitial lung disease in the United States
The study findings demonstrate a substantial proportion of patients with fibrosing ILD initiated oxygen therapy following initial ILD diagnosis, with higher rates of oxygen therapy initiation observed among patients with IPF compared with non-IPF ILD. Respiratory comorbidities were key factors associated with increased initiation of oxygen therapy.
Authors
- Sreenivas P. Veeranki (ORCID: https://orcid.org/0000-0002-8645-1990)
- Amy Anderson (ORCID: https://orcid.org/0000-0002-1067-3204)
- Gursimran Basra
- Amy L. Olson (ORCID: https://orcid.org/0000-0002-5368-0412)
- Andrea Steffens
- João A. de Andrade (ORCID: https://orcid.org/0000-0002-3743-4561)
- Joseph Yuan‐Mou Yang (ORCID: https://orcid.org/0000-0003-4081-7157)
Institutions
- Optum (United States) (US)
- Boehringer Ingelheim (United States) (US)
- Vanderbilt University Medical Center (US)
Publication Details
- Journal
- Respiratory Research
- Published
- 2025-02-28
- DOI
- https://doi.org/10.1186/s12931-025-03139-3
- Citations
- 3
- Primary Topic
- Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis
- Type
- article
- Field-Weighted Citation Impact
- 4.56